Frame hypotheses
Converted a broad platform story into three claims that interviews could challenge, refine, or weaken.
Innovation commercialization
NSF I-Corps Regional Program | Customer discovery case
From technical promise to an evidence-gated commercialization strategy.
Twenty stakeholder interviews helped define the core value proposition, rank five potential market pathways, and specify the scientific, market, and product evidence required before scale.
20completed stakeholder interviews
3commercial hypotheses tested
5market pathways ranked
7strategic recommendations
The starting point
A compelling technology concept still had several businesses hiding inside it.
PawMetric was conceived as an AI-enabled platform for assessing canine temperament at approximately 7 to 7.5 weeks. The technical premise opened several possible routes: working-dog selection, research and product development, consumer guidance, shelter support, and animal-health applications.
The assignment was not to choose the largest imaginable market. It was to identify where the information could improve a real decision, determine what evidence was missing, and sequence the lowest-regret path to commercialization.
Entrepreneurial Lead contribution
Customer discovery was designed as a decision system, not a collection of anecdotes.
Conduct discovery
Completed 20 stakeholder interviews across potential users, evidence partners, and commercial pathways.
Code the signal
Structured qualitative evidence into support scores, recurring needs, objections, and proof requirements.
Prioritize pathways
Built a weighted model to compare strategic fit, evidence strength, buyer urgency, and execution complexity.
Three hypotheses tested
The concept earned interest. The interviews also raised the evidence bar.
Directional coded support scores from 20 qualitative interviews, on a 1 to 5 scale. They are decision aids, not population-level estimates.
H1Objective early behavioral data addresses an unmet need
4.20/5
The strongest signal supported a need for more objective information earlier in a dog’s development.
H2Temperament may inform more personalized products
4.05/5
Stakeholders saw potential in translating temperament insight into more relevant product or care decisions.
H3Behavioral segmentation may differentiate products
3.65/5
The concept was plausible, but the path to a differentiated offer required more evidence and a clearer buyer use case.
What the evidence changed
The strongest signal was paired with a clear warning: value depends on validation and actionability.
Stakeholders did not reject the core premise. They defined the conditions under which it could become useful: longitudinal evidence, a shared definition of temperament, outputs that change a decision, and proof of an economic buyer.
Coded interview themeFrequency
Objective data is valuable
14
Longitudinal validation is required
10
Outputs must be actionable
10
Consumer demand needs proof
6
Temperament needs a consistent definition
5
The ROI and business case must be explicit
5
The workflow must remain simple
4
Working-dog programs offer a beachhead
4
Claims and regulatory questions need definition
4
Frequencies show coded appearances across the interview set. They indicate direction and salience, not statistical prevalence.
Five pathways ranked
A transparent model turned several plausible markets into one practical sequence.
Working-dog validation
Best near-term beachhead for generating longitudinal proof in a setting with observable outcomes and high decision stakes.
4.45
Pet-nutrition R&D
Promising strategic fit, provided the relationship between temperament, intervention, and measurable benefit can be established.
3.70
Consumer guidance
Intuitive value story, but demand, willingness to pay, and the form of an actionable recommendation still need proof.
3.55
Shelter and rescue
Meaningful potential use case with adoption, resource, workflow, and validation constraints that must be addressed.
3.30
Animal-pharma behavioral targeting
A longer-horizon option whose claims, mechanism, evidence burden, and partner economics were not yet sufficiently developed.
2.40
THE STRATEGIC INTERPRETATION
The highest-ranked path was a validation beachhead, not the broadest addressable market. Working-dog settings offered a focused environment with observable outcomes and meaningful decision stakes, making them the most useful place to build proof before pursuing larger product claims.
Recommended commercialization sequence
Earn the right to scale through three evidence gates.
STAGE
Scientific proof
Run a longitudinal working-dog pilot using consistent temperament constructs and clearly defined outcomes.
EVIDENCE TO BUILD
Repeatability, predictive validity, construct clarity, and the limits of any responsible claim.
DECISION UNLOCKEDCan the signal support a credible and useful interpretation?
STAGE
Market proof
Conduct independent demand and ROI research around specific buyer decisions rather than interest in the technology alone.
EVIDENCE TO BUILD
Priority use cases, adoption intent, willingness to pay, buying process, and measurable economic value.
DECISION UNLOCKEDWhich segment and buyer justify focused commercialization?
STAGE
Product proof
Translate outputs into simple recommendations, a practical workflow, and a disciplined claims and regulatory pathway.
EVIDENCE TO BUILD
User comprehension, actionability, workflow fit, implementation burden, and partner-ready product requirements.
DECISION UNLOCKEDWhat must the product deliver for a user or partner to act?
Seven recommendations
The resulting roadmap addressed science, market, product, and execution risk.
- 01
Use working-dog programs as the first validation environment.
- 02
Define a consistent and defensible temperament taxonomy.
- 03
Test predictive value longitudinally before expanding claims.
- 04
Convert technical outputs into clear next-best actions for the user.
- 05
Keep collection and interpretation simple enough for the target workflow.
- 06
Establish independent demand, willingness-to-pay, and ROI evidence.
- 07
Clarify claims and regulatory implications before broader product targeting.
Transferable commercialization judgment
What this case demonstrates beyond animal health.
Lead with the decision, not the sensor.
Stakeholders responded most clearly when the discussion centered on a consequential decision the information could improve.
Choose a beachhead that accelerates learning.
The highest-ranked pathway was not the broadest market. It was the environment most capable of producing credible evidence.
Quantify qualitative evidence without overstating it.
A coding framework made patterns and tradeoffs visible while preserving the directional nature of customer discovery.
Let discovery change the roadmap.
The interviews shifted the priority from broad product positioning toward validation, actionability, and proof of demand.
Public-safe case summary. Company-confidential details, stakeholder identities, raw interview records, and proprietary technical details are intentionally omitted. The case describes a commercialization recommendation for an early concept and does not claim scientific validation.
The broader practice
Customer discovery matters when it changes what gets built next.
This case sits within a broader practice spanning scientific-asset evaluation, competitive intelligence, market research, forecasting, valuation, and commercialization strategy.